A Comparative Clinical Study on The Effect of Kottamchukkadi and Kolakulathadi Upanaha Sweda in Janusandhigatavata


Authors : Dr Anju K V

Volume/Issue : Volume 7 - 2022, Issue 6 - June

Google Scholar : https://bit.ly/3IIfn9N

Scribd : https://bit.ly/3RvroFg

DOI : https://doi.org/10.5281/zenodo.6820382

Sandhigatavata (osteoarthritis) is characterised by Sandhi Shoola (pain in joints), Shotha (swelling), Prasarana Aakunchana Pravrutti Vedana (painful flexion and extension).Osteoarthritis is the leading cause of disability in India affecting over 15 million Indians each year. There is a steady rise in prevalence from age 30-65 years. Upanaha Sweda (hot poultice)is one among the modality of Swedanaused widely in the management of Sandhigatavata, which is found to be beneficial clinically too. Descriptions about Upanaha Sweda are available in classics and it governs its own importance. Drugs used in the present study of Upanaha alleviate the cardinal symptoms of Sandhigatavata (osteoarthritis)i.e. SandhiShoola, Shotha, Prasarana Aakunchana Pravrutti Vedana. Drugs used in Kottamchukkadi Upanaha and Kolakulathadi Upanaha are having Vatahara and Shothaharaaction. The study was conducted on 40 Patients fulfilling the diagnostic and inclusion criteria belonging to either sex. They were randomly allocated into 2 groups A &B.Group A were administered with Kottamchukkadi Upanaha and Group B with Kolakulathadi Upanaha for 7 days. Patients were assessed on 1stday before treatment, 8th day after treatment and 14th day of follow up.

Keywords : Sandhigatavata, Osteoarthritis, Upanaha Sweda, Kottamchukkadi Churna, Kolakulathadi Churna,

CALL FOR PAPERS


Paper Submission Last Date
31 - March - 2024

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe